Doğan Bahadır İnan

Doğan Bahadır İnan

Auto-generated profile, based on publicly available information

Doğan Bahadır İnan

Niğde Ömer Halisdemir University, Faculty of Medicine, Department of Pediatric, Niğde, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
MAMustafa Argun
Mustafa Argun
DİDoğan Bahadır İnan
Doğan Bahadır İnan
HÖHatice Tuna Hörmet Öz
Hatice Tuna Hörmet Öz
Mustafa Orhan DUYARMustafa Orhan DUYAR
Mustafa Orhan DUYAR
GBGöksu Başargan
Göksu Başargan
IÇIlhami Çelik
Ilhami Çelik
Objective: The reasons for a high prevalence of asymptomatic or mild coronavirus disease (COVID-19) and rare severe disease in children have been explained by non-immune and immune mechanisms. This study aimed to evaluate the immune system’s response to severe acute respiratory syndrome coronavirus 2 by investigating lymphocyte subsets. Materials and Methods: This study included 33 coronavirus disease positive children, of whom 12 had mild disease and 21 had an asymptomatic infection as the patient group and 26 ageand gender-matched healthy children as the control group. The demographic information, symptoms, physical examination findings, complete blood count, C-reactive protein (CRP), procalcitonin, and lymphocyte subsets were recorded in all subjects. Results: Leukocyte, lymphocyte, monocyte count, and hemoglobin levels of our pediatric coronavirus disease patients were similar to the control group. Neutrophil was lower in the coronavirus disease cases compared to the control group. CRP and procalcitonin levels of asymptomatic cases were similar to the control group. B cell count, CD8+ T cell count, and CD4/CD8 ratio (dividing the CD4 cell count by the CD8 cell count) ratio were similar in the patient and control groups. Natural killer, T cell, and CD4+ T cell counts were significantly higher in the whole patient group compared to the control group. Conclusion: One reason for mild severe acute respiratory syndrome coronavirus 2 infection in children may be an increase in some lymphocyte subsets such as natural killer cells, T cell, and CD4+ T cell. Understanding the answer to the question of why children develop more protective immunity to the virus could be an essential step for developing new treatments. Cite this article as: Argun M, Bahadır İnan D, Tuna Hörmet Öz H, et al. Lymphocyte subsets in mild COVID-19 pediatric patients. Turk Arch Pediatr. 2022;57(2):210-215.

20 October 2021 in Archives de Pédiatrie
Verified
Journal Article
Closed access
OBOsman Baştuğ
Osman Baştuğ
DİDoğan Bahadır İnan
Doğan Bahadır İnan
AOAhmet Ozdemir
Ahmet Ozdemir
BCBinnaz Celik
Binnaz Celik
FBFunda Baştuğ
Funda Baştuğ
CKCigdem Karakukcu
Cigdem Karakukcu

1 March 2024 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
EBErgul Bayram
Ergul Bayram
DADurmuş Ayan
Durmuş Ayan
TBTevfik Balcı
Tevfik Balcı
KAKader Zeybek Aydoğan
Kader Zeybek Aydoğan
DIDogan Bahadır Inan
Dogan Bahadır Inan
UKUmut Karabay
Umut Karabay
Background/Aim: Epidemiological investigations consistently indicate a widespread deficiency and insufficiency of vitamin D on a global scale. Vitamin D deficiency can lead to various acute and chronic diseases, including pre-eclampsia, autoimmune disorders, cardiovascular diseases, certain cancers, type 2 diabetes, and neurological disorders. However, the relationship between vitamin D status and its implications for global and public health has not been comprehensively explored. Notably, the differing clinical decision thresholds for diagnosing vitamin D deficiency and insufficiency established by various associations can create diagnostic confusion. Therefore, our study aimed to assess the distribution of vitamin D levels in Niğde province, considering variations by month, gender, and season, with respect to the clinical decision thresholds defined by different associations. Methods: The study sample comprised 57,731 cases (71% women and 19% men) admitted to our hospital between January 2021 and December 2022. We retrospectively evaluated 25-hydroxyvitamin D (25(OH)D) levels based on months, seasons, age, and gender. Additionally, we examined 25(OH)D levels separately using the clinical decision thresholds set by the Vitamin D Council, the Endocrine Society, and the Food and Nutrition Board. Patients with chronic renal insufficiency, hepatic insufficiency, and gastrointestinal malabsorption were excluded from the study, encompassing patients of all age groups. Furthermore, we categorized patients into different age decades and analyzed their vitamin D levels. We compared the same months in 2021 and 2022, monitoring changes in vitamin D levels throughout the year. Vitamin D levels were measured using the electrochemiluminescence assay (ECLIA) on a Roche Cobas E801 instrument. Results: When comparing the same months in 2021 and 2022, there was no statistically significant decrease or increase in 25(OH)D levels (The P-values for January and December were 0.066, 0.395, 0.907, 0.465, 0.705, 0.541, 0.625, 0.860, 0.695, 0.549, 0.892, and 0.838, respectively). Vitamin D insufficiency was observed in 70.3% of women and 29.7% of men. Participants under one year of age exhibited the highest mean 25(OH)D level (34.9 ng/mL), while participants between 20 and 29 years of age had the lowest mean 25(OH)D level (15.7 ng/mL). The lowest mean 25(OH)D level was recorded in April 2022 (15.6 ng/mL), whereas the highest mean 25(OH)D level was observed in July 2021 (22.7 ng/mL). There was a slight negative correlation between age and 25(OH)D levels (r=-0.038, P<0.001). The Vitamin D Council classification identified the highest number of patients with vitamin D deficiency (n=50,833; 88%). The Food and Nutrition Board included the lowest number of patients with vitamin D deficiency (n=15,049; 26.1%). Conclusion: Vitamin D deficiency is prevalent in Niğde province, particularly among women, and remains a significant public health concern. We advocate for the adoption of a unified clinical decision threshold and the expansion of the national vitamin D supplementation program to encompass adolescents and adults.

1 December 2021 in Güncel Pediatri
Verified
Journal Article
Closed access
BCBinnaz Celik
Binnaz Celik
MDMurat Doǧan
Murat Doǧan
DİDoğan Bahadır İnan
Doğan Bahadır İnan
SSSüleyman Sunkak
Süleyman Sunkak
ESEsma Saatçi
Esma Saatçi
FTFiliz Tubaş
Filiz Tubaş

21 February 2022 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
SSSuleyman Sunkak
Suleyman Sunkak
MAMustafa Argun
Mustafa Argun
BCBinnaz Celik
Binnaz Celik
OTOnur Tasci
Onur Tasci
AOAgah Bahadir Ozturk
Agah Bahadir Ozturk
MDMurat Dogan
Murat Dogan
Azithromycin is used to treat pediatric COVID-19 patients. It can also prolong the QT interval in adults. This study assessed the effects of azithromycin on ventricular repolarization in children with COVID-19. The study prospectively enrolled children with COVID-19 who received azithromycin between July and August 2020. An electrocardiogram was performed before, one, three, and five days post-treatment. Using ImageJ®, the following parameters were measured: QT max, QT min, Tp-e max, and Tp-e min. The parameters QTc max, QTc min, Tp-ec max, Tp-ec min, QTcd, Tp-ecd, and the QTc/Tp-ec ratio were calculated using Bazett's formula. The study included 105 pediatric patients (mean age 9.8±5.3 years). The pretreatment heart rate was higher than after treatment (before 92 [79–108]/min vs. Day 1 82 [69–108)]/min vs. Day 3 80 [68–92.2]/min vs. Day 5 81 [70–92]/min; p=0.05). Azithromycin does not affect the ventricular repolarization parameters on ECG in pediatric COVID-19 cases.